Zobrazeno 1 - 10
of 31
pro vyhledávání: '"K Y, Pak"'
Autor:
Ban-An Khaw, K. Y. Pak, Z. Liu, S. D. Hocherman, Gerald Johnson, Robert D. Okada, D. R. Okada
Publikováno v:
Journal of Nuclear Cardiology. 10:168-176
Technetium-99m glucarate is a myocardial infarct-avid imaging agent. Recent conflicting and inconclusive reports have suggested that the agent may be taken up by ischemic but viable myocardium. The purposes of this study were (1) to determine conclus
Publikováno v:
Journal of Physics B: Atomic, Molecular and Optical Physics. 49:074002
Autor:
E.B. Koenders, Roland A. M. J. Claessens, Frans H.M. Corstens, Otto C. Boerman, J. G. Tibben, K. Y. Pak, Leon F.A.G. Massuger, George F. Borm
Publikováno v:
Nuclear Medicine and Biology. 21:17-24
A new 99m Tc labelling method using a cleavable chelator, RP-1, was developed. In this study Balb/c mice with ovarian carcinoma xenografts received various Fab′ fragments labelled with 99m Tc either directly or via RP-1. Kidney uptake was significa
Autor:
G, Mariani, G, Villa, P F, Rossettin, P, Spallarossa, G P, Bezante, C, Brunelli, K Y, Pak, B A, Khaw, H W, Strauss
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 40(11)
Definitive diagnosis of acute myocardial infarction early in the process is often difficult. An imaging agent that localized quickly and specifically in areas of acute necrosis could provide this critical diagnostic information. To determine whether
Publikováno v:
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 4(4)
Similar to other 99mTc-based infarct-avid agents, 99mTc-glucarate localizes in myocardial infarcts. Whether severely ischemic viable myocytes sequester 99mTc-glucarate is uncertain. To assess the infarct specificity, in vitro and in vivo studies were
Autor:
Ban-An Khaw, D Bacciardi, L. Bodei, N Molea, Romano Bianchi, J. Narula, H. W. Strauss, E Lazzeri, Giuliano Mariani, K. Y. Pak, L. DiLuca
Publikováno v:
Radioactive Isotopes in Clinical Medicine and Research ISBN: 9783034877749
99mTc-D-Glucaric acid (99mTcGLA) favourably accumulates in animal models of acute ischemia/early myocardial necrosis and in human tumor xenografts. This study evaluated the biodistribution pharmacokinetics and radiation dosimetry (using the MIRD appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55715ac05d506b4970e9e7c1971448dd
https://doi.org/10.1007/978-3-0348-7772-5_54
https://doi.org/10.1007/978-3-0348-7772-5_54
Autor:
Margreet Jonker, G. Treacy, K. Y. Pak, A. F. Lobuglio, J. Iuliucci, S.H. Tam, E. Wilson, K. Bakker, P. van Eerd, W. Slingerland, P. E. Daddona, G. Riethmüller, Peter Rieber
Publikováno v:
Clinical and experimental immunology. 93(3)
SUMMARY Chimeric M-T412 (cM-T412). an anti-CD4 antibody, was tolerated in chimpanzees at a dosage of 5 mg/kg per day for up to 7 consecutive days, or 5 mg/kg per dose, twice weekly for 4 weeks. All cM-T412-treated chimpanzees showed a prolonged CD4 c
Autor:
K. Y. Pak, Leon F.A.G. Massuger, P. Kenemans, S. P. Strijk, Roland A. M. J. Claessens, F.H.M. Corstens, J. G. Tibben, C. P. T. Schijf
Publikováno v:
Nuclear medicine communications. 13(12)
Fab' fragments of the monoclonal antibody OV-TL 3, that recognizes an ovarian carcinoma-associated antigen (OA3), were labelled with 99Tcm using D-glucarate as a ligand. Twenty patients suspected of having primary or recurrent ovarian cancer received
Autor:
J E, Looney, D M, Knight, M, Arevalo-Moore, H, Trinh, K Y, Pak, M R, Dalesandro, E P, Rieber, G, Riethmuller, P E, Daddona, J, Ghrayeb
Publikováno v:
Human antibodies and hybridomas. 3(4)
The use of murine anti-CD4 monoclonal antibodies (MAbs) has shown considerable promise for the treatment of allograft rejection and rheumatoid arthritis. We have constructed mouse-human anti-CD4 antibodies with the goal of increasing their clinical p
Autor:
K Y, Pak, M A, Nedelman, M, Kanke, B A, Khaw, J A, Mattis, H W, Strauss, R T, Dean, H J, Berger
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 33(1)
An instant kit method for labeling antibody Fab' fragments was developed. The method utilizes a ligand exchange reaction between the intermediate complex 99mTc-D-glucarate and the free sulfhydryl groups on the antibody Fab' fragment. Radiolabeling of